there goes bta remaining cash, page-4

The expansion is for the delivery of the BARDA contract. The news indicates that Biota's Lani ROW program is moving. How can someone say this is not good thing?

As for the cost, we have been told that the cost (at least most of ) of Lani program is to be met by the contract.


This is actually a great news.


According to the estimated Milestones of the company, Lani Phase I Asthma studies will commence in Quarter 4 of FY12. And the HRV Phase IIb trial result will also be announced in the same quarter.


Good luck to all holders.